Growth patterns of Chinese patients with Prader-Willi syndrome

Hongbo Yang1, Mengqi Zhang1, Hongmei Song2

  • 1Key Laboratory of Endocrinology of the Ministry of Health, Department of Endocrinology, Peking Union Medical College Hospital, Beijing, China.

Congenital Anomalies
|April 23, 2015
PubMed

Insights

Prader-Willi syndrome (PWS) patients in China experience growth retardation and early-onset obesity. Their growth patterns resemble Caucasian PWS patients, suggesting a need for early intervention with growth hormone therapy.

Area of Science:

  • Pediatrics
  • Genetics
  • Endocrinology

Background:

  • Prader-Willi syndrome (PWS) is a complex genetic disorder affecting multiple systems.
  • Understanding PWS growth patterns in diverse populations is crucial for effective management.
  • Previous studies on PWS growth have primarily focused on Caucasian populations.

Purpose of the Study:

  • To investigate the spontaneous growth and weight gain patterns in patients with Prader-Willi syndrome (PWS) in Mainland China.
  • To compare the observed growth data with standardized growth curves and Caucasian PWS data.
  • To identify the optimal timing for potential interventions.

Main Methods:

  • Retrospective analysis of 120 PWS cases diagnosed between 1994 and 2014 in Mainland China.
  • Comparison of patient growth data (height, weight, BMI) with standardized growth charts.
  • Analysis of growth patterns relative to age and comparison with established PWS growth data.

Main Results:

  • Birth length was similar to the normal population, but birth weight was below the 50th centile.
  • After age 5, 43% of patients fell below the 3rd centile for height.
  • By age 3, 65.9% exceeded the 97th centile for weight, with 92.9% showing obesity (BMI > 97th centile) by age 2-3.
  • Final mean adult heights were significantly below average Chinese heights for both males and females.
  • The observed growth pattern in Chinese PWS patients is comparable to that of Caucasian PWS patients.

Conclusions:

  • PWS patients in Mainland China exhibit significant growth retardation and early-onset obesity.
  • The growth trajectory aligns with that observed in Caucasian PWS populations.
  • Early intervention with recombinant human growth hormone is recommended due to early growth issues and obesity onset.